Media & Insights

Insight

What is the process for applying for funding? It is not the deck

See why a defined milestone, detailed use of funds and the right capital type matter more than a polished pitch.

GI Network Editorial
GI Network Editorial

Editorial desk

Published 28 October 2026
WasteHero funding roadmap showing sales, product and support allocations
Photo: Nothing Ahead / pexels

Applying for startup funding starts before investor outreach. Founders need to identify the next meaningful milestone, calculate the money and runway needed to reach it, test the assumptions behind the plan, and then select a funding structure that matches both the business and the funder’s expectations.

Key takeaways
  • ·Begin with the milestone that makes the business less risky or more valuable, not with a list of potential investors.
  • ·Turn the funding ask into named costs, measurable outcomes, a timetable and a buffer.
  • ·WasteHero’s €8 million raise shows how an operating roadmap can make a funding request easier to examine, though the supplied case account does not report whether its three-year ARR targets were achieved.
  • ·Different capital providers want different things: grant funders want defined deliverables, lenders need a credible repayment path, and equity investors need a plausible route to future value.
  • ·The available cases support a practical point, not a universal benchmark: funders can make better decisions when each cost is tied to a milestone they can inspect.
  • ·A compelling deck cannot compensate for vague use of funds, unclear milestones or a mismatch between the business and the capital structure.

WasteHero, the European software company serving the waste-management sector, raised €8 million with a remarkably simple promise attached to it. The money was not presented as fuel for some misty idea of growth. It was linked to a three-year roadmap for annual recurring revenue, moving from €5 million to €10 million to €15 million.

The company divided planned spending into sales at 40%, product at 30% and support at 30%. Annual recurring revenue, usually shortened to ARR, is the subscription income a business expects to receive each year. WasteHero also set out projected returns.

That is what made the raise legible.

An investor could disagree with the targets. They could question whether the sales team would deliver them, or whether the product budget was sufficient. But they did not have to guess what the €8 million was supposed to do. Runway Team’s account of the raise says each part of the request had a job.

There is an important limit to the story. The material supplied for this article reports the raise and the proposed roadmap, but not whether WasteHero subsequently reached its €5 million, €10 million or €15 million ARR targets. That outcome should not be assumed. The useful lesson is narrower: before the money arrived, investors had a claim they could test.

WasteHero linked its €8 million raise to a three-year annual recurring revenue roadmap and a defined sales, product and support allocation.

WasteHero linked its €8 million raise to a three-year annual recurring revenue roadmap and a defined sales, product and support allocation. The supplied case account does not report whether the roadma. Photo: Nothing Ahead / Pexels, Pexels licence (free commercial use).

Most founders are taught to start elsewhere. Build the deck. Find the investors. Tell the story. Make the market sound enormous.

Those things may matter later. Yet the WasteHero case raises a more awkward question: what, exactly, is an investor being asked to finance?

The answer should not be “our growth”. It should be a defined piece of work that changes the company’s position before the cash runs out.

The deck is not the plan

Imagine you need money for a journey. You would not begin by asking every possible lender for petrol money. First, you would work out where you are going, how far away it is, what transport you need and whether you can afford the return trip.

Startup funding works much the same way. The process starts with a milestone: the next result that makes the business more credible, commercially stronger or less risky.

For a software company, that could be early customer traction. For a regulated medical technology business, it may be clinical or regulatory progress. For hardware, it could be a production stage with a properly costed budget. The point is not merely to stay busy. “Hire people” is an activity. “Reach the customer, product or regulatory proof that makes the next decision possible” is a milestone.

This is where most people stop looking. They see a funding round as a vote of confidence. A capable funder sees it as an attempt to buy down uncertainty.

The founder’s work is to make that uncertainty visible, finite and testable.

Business district - Lagos Nigeria

Nigeria. Photo: Joshua Doubek / Wikimedia Commons, CC BY-SA 4.0.

Start at the finish line

A mobile health startup provides the clearest version of the method. The company planned to raise a Series A round in 18 months. Rather than begin with an investor list, it researched comparable rounds and concluded that investors would expect 50,000 monthly active users, clinical validation and a healthcare partner.

Then it worked backwards.

The plan assigned $70,000 to a research coordinator, $40,000 to regulatory compliance, $300,000 a year to the product team, $8,000 a month to marketing and $120,000 a year to a business-development lead. Its 18-month budget came to about $980,000. It raised $1.1 million.

The business also set quarterly checkpoints. When monthly active users lagged, it changed its acquisition strategy before the planned fundraising point arrived.

The account, published by Jembon’s Failure Course, does not name the startup. So its specific commercial outcome cannot be independently judged from the supplied evidence. But the sequence matters. It did not raise money and hope that progress followed. It identified the proof investors would want, calculated the work needed to produce it, and raised against that plan.

That is a different species of funding application.

Instead of saying, “We are raising to scale,” a founder can say: “This amount funds these people, this product work and these commercial activities over this period. At the end, we expect to have achieved this measurable outcome. Here is what we will do if one assumption moves against us.”

It is not magic. It is simply assessable.

The money has to fit the job

Capital is not one thing. Each funding route is a different bargain, and each provider is protecting against a different fear.

A grant provider is usually financing specified work and wants to see deliverables, costs and evidence that the project will be completed. The attraction is that grants can be non-dilutive: the funder does not take ownership. The price is discipline. A vague budget is not much use to a funder paying for a defined project.

A lender is lending money that must be repaid. Its central concern is not whether the founder can tell a persuasive story about a vast market. It is whether repayment is plausible. That is why a business considering debt must show a credible ability to service the obligation. The distinction is neatly captured in Watu’s $7m debt deal is a credit story, not a fintech story.

Equity investors receive ownership rather than scheduled repayments. They therefore need to believe the capital can create substantially more value than exists today. They will care about the milestone because it is the evidence that may justify the next stage of growth or financing.

Bootstrapping preserves ownership but asks founders to make progress with their own cash or customer revenue. Revenue-based funding, repaid from revenue, only works where there is a credible revenue stream to support those repayments.

Put these structures side by side and a pattern appears that none of the funding labels quite says outright: the right capital is determined by what the company can realistically promise back.

A grant-funded project can promise delivery. A lender needs repayment. An equity investor needs future value. A business cannot solve a repayment problem with a good equity story, or a delivery problem with a debt application.

The company that arrived with scattered papers

A pre-seed medical technology startup entered fundraising with scattered spreadsheets and an unclear cap table, the record of who owns what in a company. For a business in a regulated field, that is not a small administrative defect. It can turn an investor conversation into a hunt for missing information.

StartupCFO, the advisory firm that prepared the company’s funding pack, built a driver-based financial model, created scenario forecasts, reconciled the cap table and organised a data room for investor review.

The company is not identified in StartupCFO’s published case study supplied for this article. It should therefore be treated as an anonymised case, not as proof of a named company’s fundraising result. The case study reports that preparing the pack prevented surprises and bottlenecks during diligence; it does not disclose the startup’s name, the amount raised or the ultimate result of the seed process.

What surprised us was not the sophistication of the model. It was the basicness of the original problem. A company can have promising technology and still lose momentum because nobody can quickly establish who owns what, what assumptions drive the budget, or how the plan changes in a slower scenario.

That matters because investors are not only deciding whether they like an opportunity. They are deciding whether the assumptions beneath it can withstand scrutiny.

The slide that changed the conversation

Another case begins with a fintech founder whose use-of-funds slide contained four unlabelled segments. No amounts. No milestones. No explanation of what the money would change.

Investors kept asking the same question: what exactly are you planning to do with the money?

After the slide was redesigned to show specific hires, outcomes and a 16-month runway, the investor discussion shifted towards the product. Whitepage Studio, which documents the example, presents it as a presentation-design case rather than an independently verified financing outcome. It does not identify the fintech company or report whether a round closed.

Still, the turn in the conversation is revealing. Vague spending asks an investor to take the founder’s word for it. Named work, timing and outcomes allow the investor to inspect the proposition.

The evidence base here deserves candour. The available examples and timing figures are largely published by advisory and presentation firms, not by independent academic studies or public filing systems. They are useful as practical case accounts, but they are not a licence to claim that a particular format guarantees funding, faster closes or better terms.

That does not weaken the core idea. It tells us how to state it honestly: a milestone-linked plan makes a funding request easier to examine. Whether the business ultimately succeeds still depends on the quality of the product, the market, execution and plenty of things no spreadsheet can settle.

Hampi's ancient granite boulder landscape from Matanga Hill at sunset. Matanga Hill is one of the holy places described in the Ramayana epic

India. Photo: Vyacheslav Argenberg / Wikimedia Commons, CC BY 4.0.

When the opposite can be true

There are situations where detailed long-range planning carries less weight. A consumer app with unusually rapid user growth may need to move faster than a conventional forecast can keep pace with. And a well-connected founder may receive attention before every cost line is tidy.

But the research brief provides no named, sourced examples of founders raising substantial venture capital with rudimentary plans. The claim is often repeated because it makes a better story than preparation does. It is not evidence that an ordinary founder should treat planning as optional.

The safer assumption is that your business will be examined, your assumptions will be challenged and your use of funds will be compared with the milestone you claim it can achieve. The purpose of planning is not to make the future certain. It is to reveal what must be true for the future to work.

What founders should do before outreach

Before opening a spreadsheet template or booking investor calls, write a one-page funding decision.

Name the next milestone. Set the date by which it should be reached. List the evidence that will prove it. Cost the people and work required. Set out the downside case if progress takes longer or costs more. Then ask whether the milestone could be reached through bootstrapping, customer revenue or a smaller proof-of-concept budget.

In India, where early-stage investors look for startups that have bootstrapped to validate initial traction, the ask needs to be clearly tied to growth rather than hope. In markets with stronger grant programmes, including parts of Europe and Canada, non-dilutive funding may come before equity, but detailed project costing remains essential. Different routes. Same demand for an explanation that holds together.

If outside capital is needed, choose the provider whose bargain fits the business. Grants for defined deliverables. Debt where repayment can be supported. Equity where capital can create the kind of future value investors require.

Only after that should the pitch deck become the public face of the plan. For the next stage of that process, How Investors Read Your Pitch Deck is useful reading. A deck is where the argument is communicated. It should not be where the argument is first invented.

What investors should ask instead

For investors, the screening question is equally direct: what risk does this capital remove?

If the answer is vague, the funding structure may be wrong, the milestone may be weak or the company may simply not be ready. If the answer is specific, the investor can assess the amount, timing, evidence and downside rather than merely admiring the ambition.

Experienced investors understand that a plan is not a promise. It is a map of assumptions. The useful questions are therefore uncomfortable ones: which cost is essential to the milestone? What happens if it takes longer? What evidence will show trouble early? And is this investor being asked to take a risk that another form of capital is better suited to bear?

GI Network’s view: A funding application should be treated as a request to finance a specific reduction in risk. The strongest ask is not “fund our growth”. It is “this amount, over this period, will create these verifiable results, and this capital structure fits the business that will exist afterwards.”

GI Network would begin by stress-testing the milestone behind the ask: whether the budget can genuinely reach it, whether the runway includes a credible buffer, and whether the evidence expected at the end of the plan is sufficient for the next capital decision. We would then align the financial model, ownership records, use-of-funds narrative and diligence materials with the requirements of the relevant grant provider, lender or equity investor, before mapping capital providers whose mandate fits the proposed structure.

The Milestone Money Test

Before applying for startup funding, run every proposed raise through four questions:

  1. 1.The proof: What must be true when this money is spent that is not true today?
  2. 2.The price: What specific people, work and costs are required to make that proof possible?
  3. 3.The clock: How long will the money last, and what checkpoints reveal trouble early?
  4. 4.The bargain: Can this business provide what this funder needs: delivery, repayment or future value?

If a founder can answer all four cleanly, the funding process has a foundation. If they cannot, more outreach will not fix it. The work is still upstream.

ShareWhatsAppLinkedInX
Questions people ask

When's the right time to seek funding?

Seek funding when you can define the next milestone capital must achieve before the cash runs out. That milestone might be customer traction, clinical or regulatory progress, or a costed production stage. The key is to show the work, budget, timing and measurable outcome, rather than raising simply because the company wants to grow.

Why do you need funding?

Funding should pay for a defined piece of work that reduces uncertainty and changes the company’s position. It may fund named hires, product development, regulatory work, customer acquisition or commercial partnerships. “Growth” alone is not a sufficient purpose. Investors need to see what the money will produce and why that result makes the next decision possible.

What are you going to do with the money?

Explain the use of funds in specific categories, with amounts, timing and outcomes. WasteHero linked its €8 million raise to a three-year ARR roadmap and allocated spending across sales, product and support. A useful plan identifies the people and activities being funded, the runway they provide and the measurable milestone expected at the end.

Is it suited for bootstrapping or does it need venture funding?

The appropriate funding route depends on what the business can realistically promise in return. Bootstrapping relies on founder cash or customer revenue. Grants fund specified deliverables. Debt requires credible repayment capacity. Revenue-based funding needs a reliable revenue stream. Equity funding suits companies that can use capital to create substantially more future value for investors.

How long is the runway?

Runway should last long enough to complete the defined work and reach the next credible milestone, not simply cover a generic period of operating costs. The article gives examples of an 18-month plan for a mobile health startup and a 16-month runway in a fintech use-of-funds presentation. There is no universal runway length stated.

Sources
  • Use of Funds Slide · Runway Team · Not stated
  • Reverse Engineering Funding · The Failure Course, Jembon · Not stated
  • Medtech Fundraise Pack · StartupCFO · Not stated
  • Use of Funds Slide · Whitepage Studio · Not stated
  • Ch8 02: Reverse-Engineer Your Funding Plan (Or Watch Investors Do It For You) | The Failure Course
  • Use of Funds Slide: The Structure and Credibility Signals Investors Expect
  • Use of Funds Slide: The 5 Elements Investors Want to See
  • Med-Tech Seed Raise: An Investor-Ready Fundraising Pack
  • Startup Funding FAQ 2026: Bootstrap to Series A | IdeaProof
Reviewed by the GI Advisory Team
GI Network

Raising capital? Open a capital file and let the advisory team assess your position.

Apply for Capital

Seeking capital?

Your application is the first step into the GI Network capital process.

Apply for Capital